Blood–Brain Network-Based Polygenic Risk Scores Reveal Biomarker Signatures and the Progression of Alzheimer’s Disease
Open Access
- 10 April 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 2885
Abstract
Background: Polygenic risk scores for Alzheimer’s disease (AD), organized by gene networks shared between the blood and brain, may provide insights into underlying disease mechanisms common to both tissues. Methods: We derived a blood–brain network-based polygenic risk score (nbPRS) from AD-associated genetic variants for three blood-brain networks, selected by the preservation of blood and brain gene co-expression networks, and AD association. Participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI, n = 1109), Framingham Heart Study (FHS, n = 8310), the Religious Orders Study Memory Aging Project (ROSMAP, n = 1215), and Mount Sinai Brain Bank (MSBB, n = 323) were stratified into low- and high-nbPRS subgroups, then profiled using longitudinal and cross-sectional data. We compared the conversion from normal cognition to AD between nbPRS subgroups. Genes differentially expressed among low- and high-nbPRS individuals were profiled with classical neuropathological markers and we investigated potential biologically relevant pathways for the genes significantly expressed in high-risk individuals. Results: Individuals with high nbPRS in three AD-associated networks (M2, M6, M14) demonstrated significant impairment in executive function and memory performance, whereas high-risk individuals in networks M2 and M14 had significantly reduced hippocampal volume. We observed high-risk individuals in M2 and M14 developed AD at twice the rate of low-risk individuals in these networks. HLA genes were differentially expressed with transcriptome-wide significance among low- and high-nbPRS individuals in M14 and associated with neuroinflammatory and tau pathology. Conclusions: Polygenic risk scores derived from blood and brain networks can differentiate individuals with a high risk of AD conversion.Keywords
Funding Information
- National Institute on Aging (R01-AG069453)
- National Institute on Aging (U01-AG068057)
- National Institute on Aging (U01-AG082665)
- National Institute on Aging (U19-AG079774)
- National Institute on Aging (P30-AG072978)
- National Institute on Aging (R01-AG048927)
- National Institute on Aging (U01-AG081230)
- National Institute on Aging (U19-AG068753)
- National Institute on Aging (T32GM100842)
- National Institute on Aging (U24-AG041689-01)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (P30-AG10161)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (P30AG72975)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG15819)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG17917)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG30146)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG36836)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (U01-AG32984)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (U01-AG46152)
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (U01-AG61358)
- Translational Genomics Research Institute
- Illinois Department of Public Health
- Translational Genomics Research Institut
- Alzheimer's Disease Neuroimaging Initiative (U01 AG024904)
- Alzheimer's Disease Neuroimaging Initiative (W81XWH-12-2-0012)
This publication has 64 references indexed in Scilit:
- Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profilesAlzheimer's & Dementia, 2023
- The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study populationDiabetologia, 2023
- Dioscin alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative stress and inflammationBiomedicine & Pharmacotherapy, 2022
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources PanelJAMA Neurology, 2021
- Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson diseaseActa Neuropathologica, 2020
- Polygenic risk and hazard scores for Alzheimer's disease predictionAnnals of Clinical and Translational Neurology, 2019
- Genomic Risk Prediction of Coronary Artery Disease in 480,000 AdultsJACC, 2018
- Predictive utility of a genetic risk score of common variants associated with type 2 diabetes in a black South African populationDiabetes Research and Clinical Practice, 2016
- The isoform‐specific functions of the c‐Jun N‐terminal Kinases (JNKs): differences revealed by gene targetingBioEssays, 2006
- A Novel Geneiba1in the Major Histocompatibility Complex Class III Region Encoding an EF Hand Protein Expressed in a Monocytic LineageBiochemical and Biophysical Research Communications, 1996